Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | RARB | P10826 | 4/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 1/20 | 0.59 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17203727 | 0.96 | TP53 (0.74) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL1623628 | 0.94 | TP53 (0.77) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL15154875 | 0.94 | TP53 (0.77) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL6705357 | 0.94 | TP53 (0.77) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL533825 | 0.94 | TP53 (0.77) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL18302060 | 0.94 | TP53 (0.77) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL8769734 | 0.94 | TP53 (0.77) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL14901669 | 0.93 | LTA4H (0.68) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL1814631 | 0.93 | MAPT (0.62) | TP53TSHRPLA2G4BL3MBTL1RARB | |
| SCHEMBL50280 | 0.93 | GAA (0.72) | TP53TSHRPLA2G4BL3MBTL1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109456268-A | The preparation of 3, the 4- dihydro-isoquinoline Alkaloid of C1 substitutions and its medical usage | 中国药科大学 | 2019-03-12 | — | — | CN | claimed |
| US-12189290-B2 | Photosensitive resin composition, dry film using same, printed wiring board, and printed wiring board manufacturing method | RESONAC CORPORATION (JP) | 2025-01-07 | — | — | US | disclosed |
| US-11921424-B2 | Photosensitive resin composition, dry film using same, printed wiring board, and printed wiring board manufacturing method | Hitachi Chemical Company, Ltd. (FIPAS) (JP) | 2024-03-05 | — | — | US | disclosed |
| US-20230350292-A1 | PHOTOSENSITIVE RESIN COMPOSITION, DRY FILM USING SAME, PRINTED WIRING BOARD, AND PRINTED WIRING BOARD MANUFACTURING METHOD | RESONAC CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20210109444-A1 | PHOTOSENSITIVE RESIN COMPOSITION, DRY FILM USING SAME, PRINTED WIRING BOARD, AND PRINTED WIRING BOARD MANUFACTURING METHOD | RESONAC CORPORATION (JP) | 2021-04-15 | — | — | US | disclosed |
| CN-109456268-A | The preparation of 3, the 4- dihydro-isoquinoline Alkaloid of C1 substitutions and its medical usage | 中国药科大学 | 2019-03-12 | — | — | CN | disclosed |
| US-20170329220-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, CURED PRODUCT, SEMICONDUCTOR DEVICE, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR PRODUCING CIRCUIT SUBSTRATE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| EP-2966098-B1 | MODIFIED CONJUGATED DIENE POLYMER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION USING SAME | UBE INDUSTRIES (JP) | 2017-07-12 | — | — | EP | disclosed |
| US-20160009834-A1 | Modified Conjugated Diene Polymer, Method for Producing Same, and Rubber Composition Using Same | UBE INDUSTRIES, LTD. (JP) | 2016-01-14 | — | — | US | disclosed |
| EP-2966098-A1 | MODIFIED CONJUGATED DIENE POLYMER, METHOD FOR PRODUCING SAME, AND RUBBER COMPOSITION USING SAME | UBE Industries, Ltd. (JP) | 2016-01-13 | — | — | EP | disclosed |
| CN-105121478-A | Modified conjugated diene polymer, method for producing same, and rubber composition using same | UBE INDUSTRIES | 2015-12-02 | — | — | CN | disclosed |
| EP-1446388-B1 | 1,2,4-TRIAZOLE DERIVATIVES CONTAINING A SULPHAMATE GROUP AS AROMATASE INHIBITORS | STERIX LTD (GB) | 2013-01-09 | — | — | EP | disclosed |
| US-7745472-B2 | Compound | STERIX LIMITED (GB) | 2010-06-29 | — | — | US | disclosed |
| US-20090111862-A1 | Compound | RICHTER GEDEON NYRT. (HU) | 2009-04-30 | — | — | US | disclosed |
| US-7361677-B2 | Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase | STERIX, LTD. (GB) | 2008-04-22 | — | — | US | disclosed |
| US-5693253-A | OPTICALLY ANISOTROPIC FILM COMPRISING LIQUID CRYSTALLINE POLYMER HAVING POSITIVE REFRACTIVE INDEX ANISOTROPY AND SHOWING NEMATIC OR SMECTIC PHASE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-12-02 | — | — | US | disclosed |
| US-5688436-A | Optically anisotropic material, process for producing it, and retardation plate and liquid crystal display device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-11-18 | — | — | US | disclosed |
| EP-0617111-B1 | Optically anisotropic material, process for producing it, and retardation plate and liquid crystal display device using same | SUMITOMO CHEMICAL CO (JP) | 1997-09-17 | — | — | EP | disclosed |
| EP-0617111-A1 | Optically anisotropic material, process for producing it, and retardation plate and liquid crystal display device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-09-28 | — | — | EP | disclosed |
| US-4115413-A | ACID FREE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111862-A1 | Compound | QPCT, SQOR, SDHA | TP53 2727/4885TSHR 2546/4885PLA2G4B 4732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.